Daniil Gataulin
Stock Analyst at Chardan Capital
(4.70)
# 169
Out of 5,242 analysts
136
Total ratings
58.4%
Success rate
35.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KOD Kodiak Sciences | Upgrades: Buy | $14 → $61 | $36.22 | +68.42% | 5 | May 11, 2026 | |
| QURE uniQure | Maintains: Buy | $31 → $37 | $24.60 | +50.41% | 14 | Apr 30, 2026 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $4 | $1.29 | +210.08% | 9 | Mar 27, 2026 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $9.58 | +265.34% | 8 | Mar 27, 2026 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.36 | +414.71% | 17 | Mar 25, 2026 | |
| ZURA Zura Bio | Maintains: Buy | $10 → $11 | $4.09 | +169.28% | 4 | Mar 23, 2026 | |
| ANNX Annexon | Maintains: Buy | $16 | $5.04 | +217.46% | 2 | Mar 20, 2026 | |
| CRVO CervoMed | Maintains: Buy | $15 → $21 | $3.24 | +548.15% | 9 | Mar 18, 2026 | |
| IRD Opus Genetics | Maintains: Buy | $9 → $11 | $4.44 | +147.75% | 4 | Mar 12, 2026 | |
| EYPT EyePoint | Maintains: Buy | $27 → $29 | $12.50 | +132.00% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 | $0.273 | +266.30% | 12 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 | $8.03 | +161.52% | 5 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $50 | $5.97 | +737.52% | 16 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $4.83 | +293.37% | 1 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 | $20.31 | +200.34% | 7 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 | $27.91 | +82.73% | 9 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2,200 | $2.98 | +73,725.50% | 1 | Mar 7, 2024 |
Kodiak Sciences
May 11, 2026
Upgrades: Buy
Price Target: $14 → $61
Current: $36.22
Upside: +68.42%
uniQure
Apr 30, 2026
Maintains: Buy
Price Target: $31 → $37
Current: $24.60
Upside: +50.41%
Cognition Therapeutics
Mar 27, 2026
Maintains: Buy
Price Target: $4
Current: $1.29
Upside: +210.08%
MeiraGTx Holdings
Mar 27, 2026
Maintains: Buy
Price Target: $35
Current: $9.58
Upside: +265.34%
Ocugen
Mar 25, 2026
Maintains: Buy
Price Target: $7
Current: $1.36
Upside: +414.71%
Zura Bio
Mar 23, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $4.09
Upside: +169.28%
Annexon
Mar 20, 2026
Maintains: Buy
Price Target: $16
Current: $5.04
Upside: +217.46%
CervoMed
Mar 18, 2026
Maintains: Buy
Price Target: $15 → $21
Current: $3.24
Upside: +548.15%
Opus Genetics
Mar 12, 2026
Maintains: Buy
Price Target: $9 → $11
Current: $4.44
Upside: +147.75%
EyePoint
Mar 4, 2026
Maintains: Buy
Price Target: $27 → $29
Current: $12.50
Upside: +132.00%
Feb 18, 2026
Maintains: Neutral
Price Target: $1
Current: $0.273
Upside: +266.30%
Feb 18, 2026
Maintains: Buy
Price Target: $21
Current: $8.03
Upside: +161.52%
Feb 10, 2026
Maintains: Buy
Price Target: $52 → $50
Current: $5.97
Upside: +737.52%
Dec 23, 2025
Initiates: Buy
Price Target: $19
Current: $4.83
Upside: +293.37%
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $20.31
Upside: +200.34%
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $27.91
Upside: +82.73%
Mar 7, 2024
Maintains: Buy
Price Target: $2,200
Current: $2.98
Upside: +73,725.50%